Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
This is a good news. it demonstrates the financial strength of the US operation and the sale is a bonus move all along and the management has a worst case scenario backup plan.
As I have said before guys, LKT goal is for his next generation. he doesn't careless if the price is low or undervalued or that he takes on high risk project.
Regarding Taurx, I'm surprised there are inventors who are willing to buy in now given the uncertainty around the approval of the drug. Even approval is granted, there is still uncertainty on the market uptake.
The way I see it, I think the share price will only increase if this event benefits the boss. Now, in what scenarios do the increase of share price benefits the boss?
